Biomet Orthopedics (BMET) Announces Strategic Research Alliance with Massachusetts General Hospital
More News related to BMET
- Biomet (BMET) Shareholders Approve Merger
- Biomet Orthopedics, Inc. and Biomet (BMET) File Suit Against Zimmer and Others
- StreetInsider.com Pre-Open Movers 07/10
- StreetInsider.com After-Hours MoverS 07/09
- S&P Changes: AKAM, NTG, FUR
More News related to Corporate News
- Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
- IBM (IBM) Signs 5-Year Remote Managed Services Agreement with Sandhar Technologies
- Google Unveils 'Buzz' Social Sharing Tool
- Semiconductor Manufacturing Int (SMI) Confirms Seeking Alternatives for Company; No Definite Decision Made
- Highlights From KO's Q4 Conference Call: Continued Solid Growth Globally in Several Segments
Biomet, Inc. (Nasdaq: BMET) announced that Biomet Orthopedics formed a strategic research alliance with Massachusetts General Hospital to collaborate on clinical outcome research for Biomet's recently introduced Regenerex and E-Poly technologies. Massachusetts General Hospital has agreed to manage the global multi-center prospective clinical studies sponsored by Biomet to provide documented outcomes for these exciting new products.
Biomet's President and Chief Executive Officer Jeffrey R. Binder added, "We believe these clinical studies will provide the long-term clinical results to validate Biomet's Regenerex(TM) and E-Poly(TM) products as important improvements in total hip reconstruction. We look forward to working with this distinguished research hospital to advance orthopaedic technology in support of improved clinical results for patients."
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
